|
|
Volumn 4, Issue 10, 2008, Pages 505-
|
|
The cardiovascular threat of lupus
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATORVASTATIN;
CD40 LIGAND;
HOMOCYSTEINE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
ATHEROSCLEROSIS;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
DISEASE ACTIVITY;
DISEASE ASSOCIATION;
DISEASE COURSE;
EDITORIAL;
ENDOTHELIAL DYSFUNCTION;
HUMAN;
HYPERHOMOCYSTEINEMIA;
HYPERTENSION;
LIPID BLOOD LEVEL;
MORTALITY;
OBESITY;
PATIENT COUNSELING;
PATIENT EDUCATION;
PREVALENCE;
PRIORITY JOURNAL;
RISK FACTOR;
SEX DIFFERENCE;
SMOKING;
SYSTEMIC LUPUS ERYTHEMATOSUS;
CARDIOVASCULAR DISEASES;
FEMALE;
HUMANS;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
MALE;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RISK FACTORS;
SURVIVAL RATE;
|
|
EID: 53849145355
PISSN: 17458382
EISSN: 17458390
Source Type: Journal
DOI: 10.1038/ncprheum0910 Document Type: Editorial |
|
Times cited : (4)
|
|
References (0)
|
